DOCTOR CARE ANYWHERE GROUP PLC (DOC)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

DOC

DOC - DOCTOR CARE ANYWHERE GROUP PLC

FNArena Sector : Healthcare services
Year End: December
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: -3.44
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.21

15 Sep
2025

0.020

OPEN

$0.20

10.53%

HIGH

$0.21

477,686

LOW

$0.20

TARGET
$0.17 -19.0% downside
OTHER COMPANIES IN THE SAME SECTOR
ACL . AHX . ALC . BMT . EBO . HLS . IDX . M7T . MDR . MPL . MVF . NHF . PSQ . RHC . SHL .
FNARENA'S MARKET CONSENSUS FORECASTS
DOC: 1
Title FY25
Forecast		 FY26
Forecast
EPS (cps) 0.8 xxx
DPS (cps) 0.0 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio 25.9 xxx
Dividend Yield 0.0% xxx
Div Pay Ratio(%) N/A xxx
This company reports in GBP.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 0.00

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxx-3.3
DPS All xxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxx76.2 M
Book Value Per Share xxxxxxxxxxxx-0.4
Net Operating Cash Flow xxxxxxxxxxxx0.7 M
Net Profit Margin xxxxxxxxxxxx-13.06 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxx-652.25 %
Return on Invested Capital xxxxxxxxxxxx-62.22 %
Return on Assets xxxxxxxxxxxx-29.73 %
Return on Equity xxxxxxxxxxxx-652.25 %
Return on Total Capital xxxxxxxxxxxx-46.17 %
Free Cash Flow ex dividends xxxxxxxxxxxx0.7 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxx0 M
Long Term Debt xxxxxxxxxxxx16 M
Total Debt xxxxxxxxxxxx17 M
Goodwill - Gross xxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxx11 M
Price To Book Value xxxxxxxxxxxx-

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxx3.2 M
Capex % of Sales xxxxxxxxxxxx4.20 %
Cost of Goods Sold xxxxxxxxxxxx37 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxx48 M
Research & Development xxxxxxxxxxxx6 M
Investments - Total xxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Bell Potter

03/09/2025

3

Downgrade to Speculative Hold from Buy

$0.17

-19.05%

Bell Potter downgrades Doctor Care Anywhere to Speculative Hold from Speculative Buy, with the target raised to 17c from 12c, which includes any potential dilution from the convertible note that remains an overhang on the stock.

Post the cessation of the secondary care pathway, the analyst points to a decline in interim 2025 revenue of -12% to GBP17.9m, with an improvement in the gross margin by 820pts to 63.3%. Operating costs and overheads fell by net circa -27%, or savings of GBP3.8m.

Earnings (EBITDA) came in at GBP2.8m, which met guidance. Bell Potter believes the change in the operating model has been highly successful, with average revenue per consult up 4.75% in 1H2025 over the prior year.

FORECAST
Bell Potter forecasts a full year FY25 dividend of 0.00 cents and EPS of 0.81 cents.
Bell Potter forecasts a full year FY26 dividend of 0.00 cents and EPS of 0.81 cents.
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
Access Extra Coverage Research History >

DOC STOCK CHART

FNArena News on DOC

1
Weekly Ratings, Targets, Forecast Changes – 05-09-25

Sep 08 2025 - Weekly Reports
2
FNArena Corporate Results Monitor – 03-09-2025

Sep 03 2025 - Australia
3
Rudi’s View: Extreme Bifurcation Ahead Of August

Jul 23 2025 - Rudi's View
4
FNArena Corporate Results Monitor – 03-09-2024

Sep 03 2024 - Australia
5
FNArena Corporate Results Monitor – 01-03-2024

Mar 01 2024 - Australia

Latest Healthcare services News

1
Better Times Ahead For Sonic Healthcare?

Jun 20 2025 - Australia
2
The Significance Of Cosmetique’s ASX Listing

Feb 26 2025 - Small Caps
3
Building The No 3 Diagnostic Imaging Player

Jun 19 2024 - Small Caps
4
Capitol Health’s Higher Margin Outlook

Mar 13 2024 - Small Caps
5
Treasure Chest: Ramsay Health Care

Oct 26 2023 - Treasure Chest
6
Timing Seems Right For Alcidion Group

Jun 21 2023 - Small Caps
7
No Enthusiasm To Combine ACL & Healius

Mar 21 2023 - Australia
8
Dr Boreham’s Crucible: Alcidion

Dec 13 2022 - Small Caps
9
No Straight Covid-Relief For Ramsay Health Care

Nov 15 2022 - Australia
10
Dr Boreham’s Crucible: Mach7 Technologies

Nov 14 2022 - Small Caps